ComplyRx

Immuno-oncology checkpoint inhibitors · Live ClinicalTrials.gov data

Durvalumab (Imfinzi) clinical trial pipeline

The timeline below tracks the 16 largest phase 2–4 durvalumab (Imfinzi) trials on ClinicalTrials.gov by enrolment, 9 of them actively recruiting. The next phase 3 primary completion among them is expected Oct 2026. Refreshed daily. Add up to four competitors to compare pipelines side by side.

16+

Major trials tracked

2

Phase 3 trials

9

Actively recruiting

Oct 2026

Next phase 3 primary completion

5,797

Participants across trials

AstraZeneca

Lead sponsor by trial count

durvalumab (16)13 active2014–2032
durvalumab
Key
Actual date
Anticipated
Forecast to primary completion
RecruitingActive, not recruitingCompletedUnknown status
'14
'16
'18
'20
'22
'24
'26
'28
'30
'32
durvalumab
SAFIR02_LungP2
Phase II Study of MEDI4736, Tremelimumab, and MEDI4736 in Combination w/ Tremelimumab Squamous Cell Carcinoma of the Head and NeckP2
An uMbrella Study of BIomarker-driven Targeted Therapy In Patients With Platinum-resistant Recurrent OvariaN Cancer(AMBITION)P2
ARIONP2
Trimodality Therapy With/Out Durvalumab to Treat Patients With Muscle-Invasive Bladder CancerP2
DG-03P2
OPTIMUMP2
NeoCOAST-2P2
LIVIGNO-2P2
DURVASCCP2
RUGBP2
AK112 Combined With Chemotherapy Versus Durvalumab Combined With Chemotherapy in Advanced Biliary Tract CancerP3
ENHANCEP2
A Phase II Study of Adjuvant Durvalumab Combined With GEMOX/GC Chemotherapy Followed by Lenvatinib Versus Capecitabine in Biliary Tract Cancer.P2
AB02P3
A Study of Lurbinectedin in Combination With Durvalumab for the Treatment of Participants With ES-SCLCP2

Upcoming readouts

11 ahead · durvalumab

Select a trial to load its full ClinicalTrials.gov record.

Key durvalumab trials

Top 12 of the 16 tracked phase 2–4 trials, ordered by phase and status. Trial names open the full ComplyRx trial page; NCT ids link to ClinicalTrials.gov.

TrialTitlePhaseStatusPrimary completion
NCT07221253AB02: A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tra…Phase 3RecruitingJul 2029
NCT06591520AK112 Combined With Chemotherapy Versus Durvalumab Combined With Chemotherapy in Advanced Biliar…Phase 3Active, not recruitingOct 2026
NCT05222971OPTIMUM: Olaparib With or Without Durvalumab for DDR Gene Mutated Biliary Tract Cancer Following Platinum…Phase 2RecruitingDec 2025
NCT07679399A Phase II Study of Adjuvant Durvalumab Combined With GEMOX/GC Chemotherapy Followed by Lenvatin…Phase 2RecruitingJan 2027
NCT06503614ENHANCE: A Trial of Durvalumab (MEDI4736) Plus Monalizumab in Non-Muscle-Invasive Bladder CancerPhase 2RecruitingDec 2027
NCT06464068DURVASCC: AGNOSTIC THERAPY IN A PHASE II SINGLE-ARM STUDY IN FIRST-LINE TREATMENT OF DURVALUMAB IN ASSOCIA…Phase 2RecruitingJan 2028
NCT07459634A Study of Lurbinectedin in Combination With Durvalumab for the Treatment of Participants With E…Phase 2RecruitingJan 2028
NCT06214572RUGB: Radiation Therapy in Unresectable Gall Bladder CancerPhase 2RecruitingJul 2029
NCT05061550NeoCOAST-2: Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung CancerPhase 2RecruitingMay 2030
NCT06109272LIVIGNO-2: A Study to Assess the Dose, Adverse Events, and Change in Disease Activity of Livmoniplimab as a…Phase 2RecruitingSept 2030
NCT03768570Trimodality Therapy With/Out Durvalumab to Treat Patients With Muscle-Invasive Bladder CancerPhase 2Active, not recruitingOct 2026
NCT04379596DG-03: Ph1b/2 Study of the Safety and Efficacy of T-DXd Combinations in Advanced HER2-expressing Gastri…Phase 2Active, not recruitingMay 2027

Track durvalumab with ComplyRx

Get an alert when a trial changes status, moves its completion date, or a new trial registers in scope. Checked nightly against ClinicalTrials.gov.

Track durvalumab

Related drug pipelines

Compare durvalumab vs pembrolizumabCompare durvalumab vs nivolumab

FAQ

How many clinical trials are running for durvalumab?
ClinicalTrials.gov lists more than 16 phase 2–4 durvalumab trials. This page tracks the 16 largest by enrolment: 14 phase 2, 2 phase 3, and 0 phase 4 among them, with 9 actively recruiting. Updated daily.
Are there clinical trials for Imfinzi?
Imfinzi is the brand name for durvalumab, so durvalumab trials on ClinicalTrials.gov cover it. ClinicalTrials.gov lists more than 16 phase 2–4 durvalumab trials. This page tracks the 16 largest by enrolment: 14 phase 2, 2 phase 3, and 0 phase 4 among them, with 9 actively recruiting. Updated daily.
Where does this data come from?
All trial data is sourced from ClinicalTrials.gov (CTGov) and refreshed on this page daily.
Can I compare durvalumab against other drugs?
Yes. The free ComplyRx Trial Pipeline tool compares up to five drugs side by side on one timeline, with PNG and PDF export. Add any competitor in the search box above.
Join the waitlist

Be the first to access ComplyRx

We'll let you know as soon as your spot opens to use ComplyRx.

By joining, you agree to our Privacy Policy.